Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date.

55 , 56 Indeed, in Study CA204-009, a strong trend toward longer PFS was reported for patients homozygous for the high-affinity FcγRIIIa V allele ( Figure 4 ).

also in 5,725 other papers